Lauren Biscaldi, MS, Managing Editor

These populations are also more likely to receive opioid analgesic therapies.

The CDC first released opioid prescribing guidelines in 2016.

Three poster presented at the ASHP Midyear Clinical Meeting delved deeper into perioperative pain management.

In a conversation from this year's Healthcare Advocate Summit, Randy Falkenrath demystified the oncology medication management model and explained how specialty pharmacist can help patients access care.

Zonisamide has a role in the treatment of epilepsy and is being explored in other central nervous system disorders.

Data demonstrated a 20% risk reduction for major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease.

The test is also the first OTC rapid antigen test cleared for any infectious disease.

Ixchiq was approved through the FDA Accelerated Approval pathway.

Vaccine manufacturers, including Novavax, are still hard at work updating immunizations against a mutating SARS-CoV-2 virus.

The drug, Zepbound, will be available in the United States by the end of 2023.

Ustekinumab-auub is approved for use in both adult and pediatric populations.

Despite societal need, stigma around MAT and MOUD still exists.

An ounce of prevention is well worth a pound of cure when it comes to DEA investigations.

Approval was based on favorable data from two ELEVATE UC phase 3 clinical trials.

The winner was announced during the 2023 NCPA Annual Convention and Expo.

Community pharmacists and their colleagues in the public health space can work together to increase STI testing and treatment in at-risk groups.

This year’s meeting will take place from October 14–17 in Orlando, Florida.

There has been growing evidence around the potential for the success of remote diabetes care and CGM technology use.

Moderna plans to begin a phase 3 trial of the combination vaccine this year.

The monovalent vaccine offers a protein-based non-mRNA option.

Vaccines were tested against various strains of the SARS-CoV-2 virus.

The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.

With a laundry list of upcoming changes, it’s more important than ever before that independent pharmacies work together.

This is the fourth approval for the drug stemming from the EMPOWER clinical trial program.

Suicides among health care professionals are estimated to occur at a higher rate than in the general public.

Although there were some differences in response after dosing, both OTC and oral prescriptions demonstrated statistically significant improvements in pain.

Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.